Impact of multimorbidity and polypharmacy on the management of patients with atrial fibrillation: Insights from the BALKAN-AF survey.

Conclusions Multimorbidity and polypharmacy were common among AF patients in our study. AT was suboptimal and approximately 18% of multimorbid patients with polypharmacy were not anticoagulated. Pattern of AF and non-emergency centre were associated with OAC non-use in AF patients with multimorbidity, whilst non-emergency centre and age ≥80 years were associated with OAC non-use in AF patients with polypharmacy. Key messages:Multimorbidity and polypharmacy are common among patients with AF.Antithrombotic therapy was suboptimal in AF patients with multimorbidity and polypharmacy.Approximately 18% of multimorbid patients with polypharmacy were not anticoagulated. PMID: 32700579 [PubMed - as supplied by publisher]
Source: Annals of Medicine - Category: Internal Medicine Tags: Ann Med Source Type: research